(Q24245014)

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

Angiographic findings in patients with refractory unstable angina according to troponin T status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Benefit of an early invasive management strategy in women with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Verapamil use in patients with cardiovascular disease: an overview of randomized trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

1 reference

7 January 2021

Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Correlation of TIMI risk score with angiographic severity and extent of coronary artery disease in patients with non-ST-elevation acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Platelet GPIIb-IIIa blockers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Improving outcome over time of percutaneous coronary interventions in unstable angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Stress test criteria used in the conservative arm of the FRISC-II trial underdetects surgical coronary artery disease when applied to patients in the VANQWISH trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice g

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

A randomized study comparing propranolol and diltiazem in the treatment of unstable angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Early angiography versus conservative treatment in patients with non-ST elevation acute myocardial infarction: MITI Investigators. Myocardial Infarction Triage and Intervention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Treatment of refractory unstable angina in geographically isolated areas without cardiac surgery. Invasive versus conservative strategy (TRUCS study)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Coronary arteriographic findings soon after non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Aspirin, heparin, or both to treat acute unstable angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Early invasive versus selectively invasive management for acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

1 reference

7 January 2021

Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021

Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815.PUB2

7 January 2021